A powerful cardiovascular combination

One newly recognised cardiovascular risk marker is atherosclerosis, where calcium-laden plaque builds up inside the arteries. Over time, arteries harden and narrow, limiting the flow of oxygen-rich blood to organs and other parts of the body.

What if a vitamin is the only compound known today to impact this calcification? Would it not be worth considering this vitamin for a heart-support formula, especially considering that science confirms it could impede and reverse this process? That is where we are with Vitamin K2. Vitamin K2 as MK-7 is the only compound – nutraceutical or pharmaceutical – shown to inhibit arterial calcification, making it an essential component for heart-support formulas.

Now consider that Omega-3 (EPA and DHA) – with qualified health claims in the United States and four EFSA claims – is one of the most recognized and accepted ingredients for cardiovascular health. Yet, the one place where Omega-3s fall short is addressing arterial calcification.

What if brand owners could build on the already credible and substantial success of Omega-3 by pairing it Vitamin K2 as MK-7, providing a complete heart-smart formula that also offers bone-health support?

NattoPharma – Gnosis by Lesaffre has driven the research to confirm the safe and efficacious benefits of Vitamin K2, providing MenaQ7® as the source material for these groundbreaking studies. The company continues to cultivate a clearer understanding of Vitamin K2's impact on human health, offering a data sheet highlighting the potential of combining K2 and Omega-3.

NattoPharma – Gnosis by Lesaffre invites you to download this new data sheet and consider for yourself if this could be the future of cardiovascular health.

Register to download our new data sheet

• Enter your email and "Lookup" to see if your details are on our system.
• Fill in your contact details if we do not have them.
• Confirm it's really you by receiving our verification email.